Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

被引:127
作者
Smadja, NV
Fruchart, C
Isnard, F
Louvet, C
Dutel, JL
Cheron, N
Grange, MJ
Monconduit, M
Bastard, C
机构
[1] Hop St Antoine, Serv Med Interne Oncol, Lab Cytogenet Hematocancerol, F-75571 Paris 12, France
[2] Ctr Henri Becquerel, F-76038 Rouen, France
[3] Hop Compiegne, Unite Hematol Oncol, Compiegne, France
[4] Hop Bichat, F-75877 Paris, France
关键词
multiple myeloma; chromosomal patterns; cytogenetic abnormalities;
D O I
10.1038/sj.leu.2401041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the cytogenetic results obtained in 81 multiple myeloma (MM) patients with abnormal karyotypes. Most karyotypes were complex with numerical and structural abnormalities but the analysis of chromosomal abnormalities allowed identification of two cytogenetic patterns depending on the chromosome number: a first hyperdiploid pattern (54%) with recurrent trisomies 3, 5, 7, 9, 11, 15 and 19 and a second pattern (46%) showing either pseudodiploid, hypodiploid or near-tetraploid karyotypes. Structural abnormalities were present in ail but five hyperdiploid karyotypes, and frequently involved lymphoid breakpoints: immunoglobulin gene regions (36 cases) or chromosome 11q13 region (21 cases). Numerous other structural aberrations were detected; the most frequent involved chromosome 1 and chromosome 13. Structural abnormalities were significantly more frequent in the second hypodiploid group. When analyzing the results obtained in the 60 patients studied at the time of diagnosis, a prognostic correlation was found between the cytogenetic pattern and overall survival: hyperdiploid patients had a longer survival than patients belonging to the pseudo/hypo/near-tetraploid group (median survival 36.8 vs 18.2 months, P < 0.04). These results suggest that MM could correspond to two closely related diseases.
引用
收藏
页码:960 / 969
页数:10
相关论文
共 38 条
[1]  
ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO
[2]  
2-I
[3]  
[Anonymous], CHROMOSOMES HUMAN CA
[4]   CHROMOSOME-1 ABERRATIONS IN CANCER [J].
ATKIN, NB .
CANCER GENETICS AND CYTOGENETICS, 1986, 21 (04) :279-285
[5]   Standard therapy versus autologous transplantation in multiple myeloma [J].
Attal, M ;
Harousseau, JL .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (01) :133-&
[6]  
BARLOGIE B, 1989, BLOOD, V73, P865
[7]  
BARLOGIE B, 1985, BLOOD, V66, P338
[8]   Diagnosis, prognosis, and standard treatment of multiple myeloma [J].
Boccadoro, M ;
Pileri, A .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (01) :111-&
[9]   Cytogenetic study of 30 patients with multiple myeloma: Comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method [J].
Brigaudeau, C ;
Trimoreau, F ;
Gachard, N ;
Rouzier, E ;
Jaccard, A ;
Bordessoule, D ;
Praloran, V .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (03) :594-600
[10]   Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma [J].
Calasanz, MJ ;
Cigudosa, JC ;
Odero, MD ;
GarciaFoncillas, J ;
Marin, J ;
Ardanaz, MT ;
Rocha, E ;
Gullon, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :418-425